A Study on Serum Uric Acid Level in Type II Diabetes Mellitus

被引:0
作者
Samin, Kashif Ali [1 ]
Ullah, Khalil [2 ]
Shah, Muhammad Ikram [3 ]
Ansari, Abidamateen [4 ]
Khalil, Sadia [5 ]
Saeed, Maryam [5 ]
机构
[1] Khyber Med Univ, Family Med, Peshawar, Pakistan
[2] Amjad Kaka Khel Clin, Mardan, Pakistan
[3] Jinnah Med Coll, Med, Peshawar, Pakistan
[4] Al Nafees Med Coll & Hosp, Med, Lahore, Pakistan
[5] Shaikh Zayed Med Complex Post Grad Med Inst, Biochem, Lahore, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 07期
关键词
Serum uric acid; Type 2 diabetes mellitus; Hypertension; PERIPHERAL NEUROPATHY; METABOLIC SYNDROME; HYPERURICEMIA; DISEASE; ASSOCIATION; MECHANISMS;
D O I
10.53350/pjmhs211572317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aim: Morbidity and mortality from non-communicable diseases, particularly diabetes are increasing rapidly in Pakistan, the prevalence has reached 17.1%. A strong association has been witnessed between type II diabetes mellitus with atherosclerosis and serum uric acid level. The current study aim was to assess the levels of serum uric acid in type II diabetes mellitus. Materials and Methods: This cross-sectional study was carried out on 85 diagnosed patients of type II diabetes mellitus in Diabetes hospital, Peshawar and the Department of General Medicine, Shaikh Zayed Medical Complex, Lahore during the period from March 2020 to August 2020.Type II diabetes mellitus (DM) diagnosed patients 85 and healthy control 30 were evaluated in this study. The level of hyperuricemia was defined for women > 6 mg/dl and men >7 mg/dl in men. Results: In this study, a total of 85 diabetic diagnosed patients and 30 healthy controls were enrolled. No significant differences were there in the baseline characteristics like anthropometric and socio-demographic parameters. The mean age for diagnosed and control cases was 58.6 +/- 8.7 and 56.5 +/- 7.6 years with an age range of 40 and 80 years. Hyperuricemia proportion among diabetic patients was 12.13% while none of the control cases had hyperuricemia. The uric acid means level increased from 4.29 +/- 0.81 mg/dl with a diabetic duration between 3 and 4 years to 4.59 +/- 0.99 mg/dl with a diabetic duration of 5 to 7 years. Furthermore, mean serum uric acid level reached 6.50 +/- 1.08 in cases with diabetic duration 8 to 12 years. Statistically, a significant association was found between diabetic duration and serum uric acid. Also, a positive correlation was found in hyperlipidemia, serum uric acid levels, and hypertension. Conclusion: In diabetic patients serum uric acid levels were found to be significantly higher. Diabetic patients had hypertension, elevated serum uric acid levels, and high triglycerides with dyslipidemia. The rise in serum uric acid levels is proportional to the duration of diabetes.
引用
收藏
页码:2317 / 2319
页数:3
相关论文
共 25 条
  • [1] Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy
    Abraham, Alon
    Breiner, Afi
    Barnett, Carolina
    Katzberg, Hans D.
    Lovblom, Leif E.
    Perkins, Bruce A.
    Bril, Vera
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 379 : 94 - 98
  • [2] Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
    Barrett, Eugene J.
    Liu, Zhenqi
    Khamaisi, Mogher
    King, George L.
    Klein, Ronald
    Klein, Barbara E. K.
    Hughes, Timothy M.
    Craft, Suzanne
    Freedman, Barry I.
    Bowden, Donald W.
    Vinik, Aaron I.
    Casellini, Carolina M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (12) : 4343 - 4410
  • [3] Association of Serum Uric Acid and Metabolic Syndrome in Type 2 Diabetes
    Bonakdaran, Shokoufeh
    Kharaqani, Banafsheh
    [J]. CURRENT DIABETES REVIEWS, 2014, 10 (02) : 113 - 117
  • [4] The role of uric acid for predicting future metabolic syndrome and type 2 diabetes in older people
    Chang, J. -B.
    Chen, Y. -L.
    Hung, Y. -J.
    Hsieh, C. -H.
    Lee, C. -H.
    Pei, D.
    Lin, J. -D.
    Wu, C. -Z.
    Liang, Y. -J.
    Lin, C. -M.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2017, 21 (03) : 329 - 335
  • [5] Duman TT, 2018, Experimental Biomedical Research, V1, P6, DOI [10.30714/j-ebr.2018136918, DOI 10.30714/J-EBR.2018136918]
  • [6] New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
    Feldman, Eva L.
    Nave, Klaus-Armin
    Jensen, Troels S.
    Bennett, David L. H.
    [J]. NEURON, 2017, 93 (06) : 1296 - 1313
  • [7] Trends in Coronary Heart Disease Epidemiology in India
    Gupta, Rajeev
    Mohan, Indu
    Narula, Jagat
    [J]. ANNALS OF GLOBAL HEALTH, 2016, 82 (02): : 307 - 315
  • [8] Rising burden of Diabetes-Public Health Challenges & way out
    Kakkar, Rakesh
    [J]. NEPAL JOURNAL OF EPIDEMIOLOGY, 2016, 6 (02): : 557 - 559
  • [9] The role of uric acid in the pathogenesis of human cardiovascular disease
    Kanbay, Mehmet
    Segal, Mark
    Afsar, Baris
    Kang, Duk-Hee
    Rodriguez-Iturbe, Bernardo
    Johnson, Richard J.
    [J]. HEART, 2013, 99 (11) : 759 - 766
  • [10] Uric Acid and Diabetes: Is there a Link?
    Katsiki, Niki
    Papanas, Nikolaos
    Fonseca, Vivian A.
    Maltezos, Efstratios
    Mikhailidis, Dimitri P.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (27) : 4930 - 4937